In compliance with current regulations, let us know which audience you belong to:
Bologna, Italy — March 24th 2022
Alessandro Fier, Matteo Corbellino and Luca Trimigno nominated amongst Forbes' 30 Under 30' Class of 2023.
In an article published in November, Espansione Group's founder, Rodolfo Pomar, and Alessandro Fier, Chief Executive Officer, have been featured on Forbes in an article sharing few key highlights of the cross-generational exchange operation the two have brought forward.
Quoting directly from the article:
To continue along this growth path, Alessandro Fier, Chief Executive Officer, shared that the company will continue to focus on research and development, as well as commercial excellence and partner support. "We are also carrying out an ambitious industrial plan," Fier tells us, "which will see major invest- ments in people and their skills, carrying out digitalization processes, development, and internal structuring to enhance the customer experience and our capabilities in terms of sales and marketing."
And, going further:
Espansione’s projects also look beyond though. The medium-term goal is to become the gold standard technology in the treatment of dry eye and the ocular surface at a global level. The North American market will remain the main focus of the business plan for its reference function, although the entry into new markets such as China and Japan is expected in the coming months—key countries for positioning the company well on the global market, and a great way to make its technologies accessible worldwide.
Read the full article by downloading the .pdf below.
Access the original article on Forbes at this link [Language: Italian]
> ABOUT ESPANSIONE GROUP
Espansione Group is an established player in the medtech industry. Every day, the company invests heavily in researching and developing the Espansione Ecosystem of technologies and solutions to achieve its ambition: establishing new paradigms in ophthalmology and beyond, driven by its desire to provide its partners and their patients with the best, certified medical technologies.
Present in over 50 countries, Espansione Group aims to continue its strong growth in the years to come, relentlessly focusing its efforts on research, development, and customer excellence.
For more information, see www.espansionegroup.it
© 2023 Espansione Group, All Rights Reserved
Posted on March 13th, 2023 in Newsroom